Molecule to Market Podcast: Unlocking the Future of Drug Discovery
Karen Lackey, CEO of X-Chem, has been at the forefront of integrated drug discovery across her over 30-year career. Hear her story and insights on the future of drug discovery in her appearance on the Molecule to Market podcast.
Listen now to explore:
- How diversity of thought enables problem-solving
- Karen’s journey from big pharma to leading biotech innovation
- How Karen’s experience empowers her to redefine drug discovery at X-Chem
- A holistic view of AI/ML in drug discovery, enabling more accessible and capital-efficient use
- Karen’s views on biotech failures and how to rethink launches